Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy

Clinical trial NCT04846673 · COMPLETED

Trial details

NCT number: NCT04846673
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathy

Start date: 2021-05-14
Primary completion: 2022-11-30
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.